Infection due to non-Aspergillus fungi in Immunocompromised patients receiving itraconazole -: Reply

被引：0

作者：

Nelson, KE

Chariyalertsak, S

Supparatpinyo, K

Sisisanthana, T

机构：

[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21201 USA

[2] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 04期

关键词：

D O I：

10.1086/341496

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：495 / 495

页数：1

共 50 条

[41] Clostridium difficile infection in non-HIV-immunocompromised patients and in HIV-infected patients
Raines D.L.
Lopez F.A.
Current Gastroenterology Reports, 2011, 13 (4) : 344 - 350
[42] Incidence of mycobacteria and fungi in clinically suspected urinary tract infection of immunocompromised patients - A tertiary care hospital study
Jain, S.
Nag, V.
Marak, R. S. K.
Prasad, N.
Dhole, T.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E206 - E207
[43] The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
Kim, Jin Seok
Cheong, June-Won
Kim, Yeo-Kyeoung
Park, Jinny
Mun, Yeung-Chul
Kang, Hye Jin
Yi, Hyeon Gyu
Lee, Je-Hwan
Kim, Yang Soo
Ryoo, Hun-Mo
Kim, Sung-Hyun
Kim, Ho Young
Kim, Jin Young
Lee, Dong-Gun
Kim, Hoon-Gu
Kim, Hawk
Joo, Young-Don
Min, Yoo Hong
ANNALS OF HEMATOLOGY, 2014, 93 (01) : 33 - 42
[44] The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
Jin Seok Kim
June-Won Cheong
Yeo-Kyeoung Kim
Jinny Park
Yeung-Chul Mun
Hye Jin Kang
Hyeon Gyu Yi
Je-Hwan Lee
Yang Soo Kim
Hun-Mo Ryoo
Sung-Hyun Kim
Ho Young Kim
Jin Young Kim
Dong-Gun Lee
Hoon-Gu Kim
Hawk Kim
Young-Don Joo
Yoo Hong Min
Annals of Hematology, 2014, 93 : 33 - 42
[45] ASPERGILLUS-FUMIGATUS PNEUMONIA IN NEUTROPENIC PATIENTS RECEIVING FLUCONAZOLE FOR INFECTION DUE TO CANDIDA SPECIES - IS AMPHOTERICIN-B COMBINED WITH FLUCONAZOLE THE APPROPRIATE ANSWER
PAHLS, S
SCHAFFNER, A
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) : 484 - 485
[46] Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis (vol 51, pg 277, 2016)
Riches, M. L.
Trifilio, S.
Chen, M.
Ahn, K. W.
Langston, A.
Lazarus, H. M.
Marks, D. I.
Martino, R.
Maziarz, R. T.
Papanicolou, G. A.
Wingard, J. R.
Young, J-A H.
Bennett, C. L.
BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 322 - 322
[47] Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients
Rodriguez, M
Fishman, JA
CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (04) : 770 - +
[48] Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients
Choi, Y-L.
Kim, J-A.
Jang, K-T.
Kim, D-S.
Kim, W-S.
Lee, J-H.
Yang, J-M.
Lee, E-S.
Lee, D-Y.
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (05) : 977 - 982
[49] Non-fumigatus Aspergillus Infection Associated with a Negative Aspergillus Precipitin Test in Patients with Chronic Pulmonary Aspergillosis
Takeda, Keita
Suzuki, Junko
Watanabe, Akira
Narumoto, Osamu
Kawashima, Masahiro
Sasaki, Yuka
Nagai, Hideaki
Kamei, Katsuhiko
Matsui, Hirotoshi
JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (02)
[50] Rates of Aspergillus Co-Infection in COVID Patients in ICU Not as High as Previously Reported Reply
White, P. Lewis
Dhillon, Rishi
Wise, Matthew P.
Backx, Matthijs
CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : E1238 - E1239

← 1 2 3 4 5 →